Press Release

Milestone for SkinVision: Three Important Certifications Achieved

SkinVision, the leading app for early skin cancer detection, recently achieved three important ISO certifications. The British Standards Institution (BSI), awarded SkinVision ISO 13485:2016 for its quality management system. Additionally, BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510:2017, which includes additional requirements to ISO 27001:2013, specifically for healthcare providers in the Netherlands, where SkinVision is based. 

Read More »

New Study Finds SkinVision Detects 95% of Skin Cancer 

Amsterdam, 12 September 2019​ – An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer. 

Read More »

SkinVision Joins the DigitalHealth.London Accelerator

Smartphone App for Skin Cancer Risk Selected to Join DigitalHealth.London Accelerator

SkinVision, a mobile application driving early skin cancer detection by empowering individuals to monitor their skin for early signs of skin cancer, has been selected to join the DigitalHealth.London Accelerator. 

Read More »